Biotron Limited BITRF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0015 Day range 0.0015
0.0011 52-week range 0.10144
- YTD
- -86.76%
- 1 year
- -90.65%
- Open
- 0.0015
- Prev close
- 0.0015
- Mkt cap
- 4.18M
- Vol
- 400.00K
- Avg vol
- 10.19K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0015
- High
- 0.0015
6M chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| RSI: Overbought | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| RSI: Oversold | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
Financial health
Altman Z-Score
-22.11 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -4.1×
FY 2017 5y median -14.3× FY 2026
P/S 11.4×
FY 2017 5y median 15.6× FY 2026
P/B 2.1×
FY 2017 5y median 7.0× FY 2026
P/FCF -3.4×
FY 2017 5y median -13.8× FY 2026
EV/EBITDA -2.9×
FY 2017 5y median -14.1× FY 2026
EV/Sales 8.4×
FY 2017 5y median 12.9× FY 2026
FCF Yield -29.6%
FY 2017 5y median -7.3% FY 2026
Profitability
Gross Margin 100.0%
FY 2017 5y median 97.5% FY 2026
Operating Margin -295.9%
FY 2017 5y median -213.1% FY 2026
Net Margin -288.3%
FY 2017 5y median -208.9% FY 2026
ROE -52.0%
FY 2017 5y median -57.7% FY 2026
ROIC -53.3%
FY 2017 5y median -61.4% FY 2026
ROA -40.6%
FY 2017 5y median -84.5% FY 2026
Growth (YoY)
Revenue -71.0%
FY 2017 FY 2026
Operating Income -359.4%
FY 2017 FY 2026
EPS (diluted) -133.3%
FY 2017 FY 2026
Free Cash Flow -211.9%
FY 2017 FY 2026
Financial Health
Current Ratio 1.9×
FY 2017 5y median 2.2× FY 2026
Quick Ratio 1.9×
FY 2017 5y median 2.2× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.0×
FY 2017 5y median 1.0× FY 2026
Interest Coverage 0.0×
FY 2017 5y median -550× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30